GlaxoSmithKline is a science-led global healthcare company on a mission to help people do more, feel better and live longer. The Company has three businesses that research, develop and manufacture pharmaceutical medicines, vaccines and consumer healthcare products. GlaxoSmithKline manufactures products for major disease areas such as asthma, cancer, infections, diabetes and mental health. 


TypePublic
HQBrentford, GB
Founded2000
Size (employees)98,462 (est)
Websitegsk.com
GlaxoSmithKline was founded in 2000 and is headquartered in Brentford, GB
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at GlaxoSmithKline

Emma Walmsley

Emma Walmsley

Chief Executive Officer of GSK
Simon Dingemans

Simon Dingemans

CFO
Hal Barron

Hal Barron

Chief Scientific Officer and President, R&D
Roger Connor

Roger Connor

President, Global Vaccines
James Ford

James Ford

Senior Vice President and General Counsel
Nick Hirons

Nick Hirons

Senior Vice President, Global Ethics and Compliance
Show more

GlaxoSmithKline Office Locations

GlaxoSmithKline has an office in Brentford
Brentford, GB (HQ)
980 Great West Rd
Show all (1)
Report incorrect company information

GlaxoSmithKline Financials and Metrics

GlaxoSmithKline Revenue

Embed Graph
GlaxoSmithKline's revenue was reported to be £30.19 b in FY, 2017 which is a 8.2% increase from the previous period.
GBP

Revenue (Q1, 2018)

7.2b

Gross profit (Q1, 2018)

4.8b

Gross profit margin (Q1, 2018), %

66.9%

Net income (Q1, 2018)

759.0m

EBIT (Q1, 2018)

1.2b

Market capitalization (11-Jul-2018)

101.9b

Closing stock price (11-Jul-2018)

41.1

Cash (31-Mar-2018)

4.0b

EV

115.4b
GlaxoSmithKline's current market capitalization is $101.9 b.
Annual
GBPFY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2016FY, 2017

Revenue

18.1b20.5b21.2b21.4b20.4b21.7b23.2b22.7b26.5b27.9b30.2b

Revenue growth, %

17%8%

Cost of goods sold

4.0b4.7b4.6b4.5b4.3b4.8b5.0b5.3b8.6b9.3b10.3b

Gross profit

14.1b15.8b16.6b16.9b16.0b16.9b18.2b17.4b17.9b18.6b19.8b
Quarterly
GBPQ1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

7.4b7.3b7.8b7.2b

Cost of goods sold

2.5b2.6b2.7b2.4b

Gross profit

4.9b4.7b5.2b4.8b

Gross profit Margin, %

66%64%66%67%
Annual
GBPFY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2016FY, 2017

Cash

1.3b716.0m1.1b962.0m1.2b4.2b2.0b3.4b5.5b4.9b3.8b

Accounts Receivable

3.3b3.6b3.5b3.7b3.8b4.4b4.4b4.6b4.0b6.0b6.0b

Inventories

2.3b2.1b2.1b2.1b2.2b2.2b2.4b3.1b3.9b5.1b5.6b

Current Assets

11.3b10.0b10.7b12.6b13.6b13.2b11.0b13.6b15.2b16.7b15.9b
Quarterly
GBPQ1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

4.5b4.0b4.7b4.0b

Accounts Receivable

6.2b6.2b6.5b6.1b

Inventories

5.4b5.7b5.7b5.7b

Current Assets

16.8b16.4b17.7b16.4b
Annual
GBPFY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2016FY, 2017

Net Income

4.3b3.2b4.0b4.6b4.4b4.8b5.5b5.3b5.6b1.1b2.2b

Depreciation and Amortization

2.0b2.9b

Inventories

70.0m(461.0m)

Accounts Payable

96.0m11.0m
Quarterly
GBPQ1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

1.2b1.1b2.5b759.0m

Cash From Operating Activities

1.1b2.2b4.0b863.0m

Purchases of PP&E

(260.0m)(639.0m)(1.0b)(258.0m)

Cash From Investing Activities

(199.0m)(646.0m)(1.1b)(371.0m)
GBPY, 2018

EV/EBIT

93 x

EV/CFO

133.7 x

Debt/Equity

4.9 x

Debt/Assets

0.3 x

Financial Leverage

15.6 x
Show all financial metrics

GlaxoSmithKline Operating Metrics

GlaxoSmithKline's Unique Visitors was reported to be 1.8 m in FY, 2015.
FY, 2014FY, 2015FY, 2016FY, 2017

Manufacturing Facilities

57 54 87

Markets

150 150 150

Unique Visitors

1.80 m

Volume of Medicines Produced

1.90 b
Show all operating metrics

GlaxoSmithKline Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
NovartisMarch 27, 2018$13 b

GlaxoSmithKline Revenue Breakdown

Embed Graph

GlaxoSmithKline revenue breakdown by business segment: 25.7% from Consumer Healthcare, 17.1% from Vaccines and 57.2% from Global Pharmaceuticals

GlaxoSmithKline revenue breakdown by geographic segment: 59.6% from International, 37.3% from US and 3.1% from Other

Report incorrect company information

GlaxoSmithKline Online and Social Media Presence

Embed Graph
Report incorrect company information

GlaxoSmithKline Company Life and Culture

Report incorrect company information